Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Chinese Medicine
  4. Vol 6, Issue 1, 2024

Gualou Xiebai Guizhi Decoction in the Treatment of Angina Pectoris in Coronary Heart Disease: A Systematic Review and Meta-analysis

Download as PDF

DOI: 10.23977/medcm.2024.060107 | Downloads: 6 | Views: 179

Author(s)

Wei Liu 1, Dan Wang 2

Affiliation(s)

1 College of Graduate, Guizhou University of Traditional Chinese Medicine, Guiyang, China
2 Department of Cardiovascular Medicine, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, China

Corresponding Author

Wei Liu

ABSTRACT

The effectiveness of the Gualou Xiebai Guizhi Decoction (GLXBGZD) in treating angina pectoris associated with coronary heart disease (CHD), a prevalent cardiovascular condition, remains a topic of inquiry. Hence, this meta-analysis systematically evaluated its efficacy in this context. A comprehensive search spanning PubMed, Web of Science, Embase, SinoMed, WanFang Database, China National Knowledge Infrastructure, and Chinese Scientific Journal Database, from inception to November 2022, was conducted to identify studies investigating GLXBGZD combined with conventional antianginal drugs for CHD-related angina pectoris. Outcome measures encompassed clinical effectiveness rate, left ventricular ejection fraction, blood lipid levels, and angina pectoris duration and frequency. Meta-analysis was performed utilizing Stata17 and Review Manager 5.4 software. The study was registered in PROSPERO under the number CRD42022375760. Seven eligible studies involving 688 patients were included. Compared to conventional treatments, GLXBGZD combined with conventional treatments exhibited a significant improvement in the clinical efficacy rate (odds ratio, 3.90; 95% confidence interval, 2.21–6.86; P <0.001). Furthermore, GLXBGZD combined with conventional treatments showed promising trends in enhancing heart function and blood lipid profiles (including reductions in total cholesterol, triglyceride, and low-density lipoprotein levels, along with an increase in high-density lipoprotein levels), as well as in reducing the duration and frequency of angina. However, we did not reach statistical significance for these outcomes (all P >0.05). In conclusion, the combination of GLXBGZD with conventional treatment demonstrated an enhanced clinical efficacy in the management of CHD-related angina pectoris. Nevertheless, there remains insufficient evidence to conclusively establish the benefits of GLXBGZD combined with conventional treatment in improving blood lipid levels and cardiac function, as well as in reducing the duration and frequency of angina pectoris.

KEYWORDS

Cardiovascular disease, Chinese herbal formula, Clinical efficacy, Blood lipids

CITE THIS PAPER

Wei Liu, Dan Wang, Gualou Xiebai Guizhi Decoction in the Treatment of Angina Pectoris in Coronary Heart Disease: A Systematic Review and Meta-analysis. MEDS Chinese Medicine (2024) Vol. 6: 43-56. DOI: http://dx.doi.org/10.23977/medcm.2024.060107.

REFERENCES

[1] Anon. (2018) Guidelines for rational drug use in coronary heart disease (2nd edition). Chinese Journal of Medical Frontiers (electronic version), 10, 1-130.
[2] Manfredi R., et al. (2022) Angina in 2022: Current Perspectives. J Clin Med, 11(23).
[3] Ford T.J. and Berry C. (2020) Angina: contemporary diagnosis and management. Heart, 106(5), 387-398.
[4] Ferrari R., et al. (2019) Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment. Eur Heart J, 40(2), 190-194.
[5] Waheed N., et al. (2019) Advances in small-molecule therapy for managing angina pectoris in the elderly. Expert Opin Pharmacother, 20(12), 1471-1481.
[6] Davies, A., et al. (2021) Management of refractory angina: an update. Eur Heart J, 42(3), 269-283.
[7] Xie A., and Wang F.R. (2013) A Brief Talk about TCM Disease Name and Pathogenesis of Chest Stuffiness and Pains. Journal of Practical Traditional Chinese Internal Medicine, (6), 161160-161+165.
[8] Teng C., et al. (2020) Study on the mechanism of Gualou Xiebai Guizhi decoction (GLXBGZD) in the treatment of coronary heart disease based on network pharmacology. Medicine (Baltimore), 101(29), e29490.
[9] Zhang Y.Y., et al. (2020) A comparative pharmacogenomic analysis of three classic TCM prescriptions for coronary heart disease based on molecular network modeling. Acta Pharmacol Sin, 41(6), 735-744.
[10] Li C., et al. (2019) Discovery of the mechanisms and major bioactive compounds responsible for the protective effects of Gualou Xiebai Decoction on coronary heart disease by network pharmacology analysis. Phytomedicine, 56, 261-268.
[11] Yang X.Y. (2020) Clinical observation of Gualou Xiebai Guizhi decoction combined with Western medicine in treating senile coronary heart disease with phlegm and blood stasis. China's Naturopathy, 28(12), 77-79.
[12] Liu A.J., and Chen H.J. (2021) Clinical Observation on Gualou Xiebai Guizhi Decoction in the Treatment of Stable Angina Pectoris of Coronary Heart Disease with Turbid Phlegm Obstruction Type. Journal of Guangzhou University of Traditional Chinese Medicine, 38(12), 2565-2571.
[13] Yang Y., et al. (2019) Effects of Gualou Xiebai Guizhi Decoction on Lipid Metabolism and Plasma Heme Oxygenase-1 and Matrix Metalloproteinase-9 Levels in Elderly Patients with Coronary Heart Disease. World Chinese Medicine, 14(10), 2732-2736.
[14] Wu Y. (2020) Effect of Gualouxiebaiguizhi Decoction on senile Coronary heart disease. Contemporary Medical Symposium, 18(14), 198-199.
[15] Li W.D. (2015) Sixty-Eight Cases of Angina Pectoris due to Acute Myocardial Infarction Treated with Gualou Xiebai Guizhi Decoction. Henan Traditional Chinese Medicine, 35(6), 1262-1263.
[16] Cao Y. (2016) Clinical effect analysis of Gualou Xiebai Guizhi decoction in treating secondary angina pectoris in acute myocardial infarction. Clinical Journal of Chinese Medicine, 8(24), 35-36.
[17] Zhang H.X., Li H.L., and Liu X.F. (2020) Effects of Gualou Xiebai Guizhi Decoction on Elderly Patients with Coronary Heart Disease. World Chinese Medicine, 15(08), 1157-1161.
[18] Hou S., Huang L., and Zeng Z. (2020) Effect of Guilou Xiebai Guizhi Decoction on Blood Lipid and NT-proBNP, hs-CRP, Fib Levels in Elderly Patients with Coronary Heart Disease. Oriental Medicated Die, (3), 14.
[19] Liu D., et al. (2022) Efficacy and safety of Xuefu Zhuyu Granules combined with western medicine in the treatment of angina pectoris of coronary heart disease: A study protocol of a randomized, double-blind, placebo-controlled clinical trial. Medicine (Baltimore), 101(43), e31235.
[20] Xu F.L., and Hu, Y.Z. (2013) Clinical Observation of Tianwang Buxin Pill in Treating Coronary Heart Disease with Insomnia. Hubei Journal of Traditional Chinese Medicine, 35(11), 53-54.
[21] Xing W.Y., et al. (2007) Study on the rule of syndrome combination of 1069 cases of angina pectoris by cluster analysis and corresponding-correlation methed. China Journal of Traditional Chinese Medicine and Pharmacy, (11), 747-750.
[22] Zhang W.R., et al. (2004) Advanced glycation end products accelerate atherosclerosis via enhancement of oxidative stress. National Medical Journal of China, (13), 14-18.
[23] Feng X., and Su L. (2023) Clinical effect of Gualou Xiebai Guizhi Decoction on stable angina pectoris of coronary heart disease with phlegm-turbidity-internal obstruction. Inner Mongolia Journal of Traditional Chinese Medicine, 42(07), 29-30.
[24] Luo G.G., et al. (2012) Relationship between plasma homocysteine and carotid atherosclerotic plaques in patients with ischemic cerebrovascular disease. Chinese Journal of Cerebrovascular Diseases, 9(03), 123-127.
[25] Yan H.Y., et al. (2015) [Pharmacodynamics Study on Gualou Xiebai Dropping Pills and Its Medicinal Ingredients in Prescription]. Zhong Yao Cai, 38(3), 567-571.
[26] Chen L., et al. (2022) Clinical effect of Gualou Xiebai Baijiu Decoction on angina pectoris of coronary heart disease. Journal of Practical Traditional Chinese Internal Medicine, 36(09), 132-135.
[27] Wang R., et al. (2020) Saponins in Chinese Herbal Medicine Exerts Protection in Myocardial Ischemia-Reperfusion Injury: Possible Mechanism and Target Analysis. Front Pharmacol, 11, 570867.
[28] Xue Y. L., et al. (2011) Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aorta. Vasc Health Risk Manag, 7, 273-280.
[29] Raffai G., et al. (2014) Cinnamaldehyde and cinnamaldehyde-containing micelles induce relaxation of isolated porcine coronary arteries: role of nitric oxide and calcium. Int J Nanomedicine, 9, 2557-2566.
[30] Lan H., et al. (2023) Cinnamaldehyde protects donor heart from cold ischemia-reperfusion injury via the PI3K/AKT/mTOR pathway. Biomed Pharmacother, 165, 114867.
[31] Luan F., et al. (2022) Cardioprotective effect of cinnamaldehyde pretreatment on ischemia/ reperfusion injury via inhibiting NLRP3 inflammasome activation and gasdermin D mediated cardiomyocyte pyroptosis. Chem Biol Interact, 368, 110245. 

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 4191
Visits: 164804

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.